View More Recent Stories
-
Artivion (AORT) Announces Presentation of Late-Breaking Clinical Data at EACTS
-
Needham Reiterates Buy Rating on Artivion Inc. (AORT)
-
Artivion Inc. (AORT) PT Raised to $30 at Oppenheimer
-
Artivion (AORT) Tops Q2 EPS by 16c ; Offers Guidance
-
Artivion Inc. (AORT) PT Raised to $30 at Lake Street Capital Markets
-
Artivion (AORT) Amends Agreements with Endospan

